Dr. Mateus Vidigal de Castro is a Gerontology Specialist (Albert Einstein, 2024) and holds a PhD and MSc in Cell and Structural Biology (UNICAMP, 2020, 2015). He completed his postdoctoral fellowship in Genetics at the Human Genome and Stem Cell Research Center (CEGH-CEL), University of São Paulo (USP), under the supervision of Prof. Dr. Mayana Zatz (2020–2024), receiving the USP Best Postdoc Award in Biological Sciences (2023). He is a member of the editorial boards of Cells and Heliyon, and serves as reviewer for Frontiers, iScience, and Immunity and Ageing. His research spans neurobiology, nerve regeneration, and the impact of viral infections on the nervous system. During the COVID-19 pandemic, he explored genetic and cellular mechanisms of susceptibility and resilience. Currently, he investigates longevity and healthy aging, focusing on resilient centenarians. Dr. Castro has experience with biosafety level 2/3 viruses, human and animal models, stem cell technologies, advanced pharmacological therapies, and the generation of spheroids and organoids.
Dr. Mateus Vidigal de Castro is a Gerontology Specialist (Albert Einstein, 2024) and holds a PhD and MSc in Cell and Structural Biology (UNICAMP, 2020, 2015). He completed his postdoctoral fellowship in Genetics at the Human Genome and Stem Cell Research Center (CEGH-CEL), University of São Paulo (USP), under the supervision of Prof. Dr. Mayana Zatz (2020–2024), receiving the USP Best Postdoc Award in Biological Sciences (2023). He is a member of the editorial boards of Cells and Heliyon, and serves as reviewer for Frontiers, iScience, and Immunity and Ageing. His research spans neurobiology, nerve regeneration, and the impact of viral infections on the nervous system. During the COVID-19 pandemic, he explored genetic and cellular mechanisms of susceptibility and resilience. Currently, he investigates longevity and healthy aging, focusing on resilient centenarians. Dr. Castro has experience with biosafety level 2/3 viruses, human and animal models, stem cell technologies, advanced pharmacological therapies, and the generation of spheroids and organoids.